Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China · Delayed Price · Currency is CNY 17.25
0.00 (0.00%)
Sep 16, 2026, 3:00 PM CST
SHA:603579 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,422 | 4,787 | 2,510 | 2,825 | 2,731 | 4,478 | |
Market Cap Growth | -49.80% | 90.74% | -11.16% | 3.44% | -39.01% | 8.83% |
Enterprise Value | 2,121 | 4,057 | 2,478 | 2,528 | 2,274 | 4,190 |
Last Close Price | 17.25 | 23.17 | 13.90 | 14.38 | 13.46 | 21.83 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.91 | 31.77 | 13.08 | 13.94 | 16.63 | 18.95 |
Forward PE | 18.16 | 22.95 | 11.69 | 12.79 | 12.94 | 15.62 |
PS Ratio | 1.95 | 3.04 | 1.57 | 1.52 | 1.36 | 1.71 |
PB Ratio | 1.23 | 1.72 | 1.25 | 1.43 | 1.46 | 2.52 |
P/TBV Ratio | 1.32 | 1.78 | 1.31 | 1.52 | 1.54 | 2.67 |
P/FCF Ratio | - | 76.09 | 147.10 | 11.09 | 20.06 | 22.79 |
P/OCF Ratio | 41.13 | 27.39 | 14.93 | 8.21 | 11.53 | 13.25 |
PEG Ratio | - | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.21 | 2.58 | 1.55 | 1.36 | 1.13 | 1.60 |
EV/EBITDA Ratio | 27.11 | 32.68 | 12.16 | 9.86 | 11.14 | 14.31 |
EV/EBIT Ratio | 84.63 | 57.53 | 16.88 | 12.87 | 15.56 | 17.49 |
EV/FCF Ratio | - | 64.49 | 145.22 | 9.93 | 16.70 | 21.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.16 | 0.06 | 0.53 | 0.38 | 0.54 | 0.39 |
Debt / EBITDA Ratio | 5.56 | 1.36 | 5.27 | 2.95 | 4.93 | 2.31 |
Debt / FCF Ratio | - | 2.68 | 62.94 | 2.97 | 7.43 | 3.55 |
Net Debt / Equity Ratio | -0.48 | -0.57 | -0.33 | -0.54 | -0.48 | -0.44 |
Net Debt / EBITDA Ratio | -17.02 | -12.81 | -3.28 | -4.13 | -4.38 | -2.66 |
Net Debt / FCF Ratio | 246.01 | -25.28 | -39.14 | -4.15 | -6.56 | -3.97 |
Asset Turnover | 0.48 | 0.43 | 0.45 | 0.55 | 0.60 | 0.84 |
Inventory Turnover | 7.12 | 7.14 | 7.38 | 7.39 | 6.09 | 7.25 |
Quick Ratio | 2.00 | 2.82 | 2.02 | 3.04 | 2.30 | 1.91 |
Current Ratio | 2.24 | 3.09 | 2.21 | 3.34 | 2.55 | 2.34 |
Return on Equity (ROE) | 7.19% | 6.25% | 9.62% | 10.58% | 9.03% | 13.30% |
Return on Assets (ROA) | 0.43% | 1.21% | 2.57% | 3.61% | 2.73% | 4.81% |
Return on Invested Capital (ROIC) | 1.42% | 4.51% | 11.85% | 18.35% | 13.57% | 22.35% |
Return on Capital Employed (ROCE) | 0.90% | 2.50% | 5.30% | 7.20% | 5.80% | 10.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.19% | 3.15% | 7.65% | 7.17% | 6.01% | 5.28% |
FCF Yield | -0.16% | 1.31% | 0.68% | 9.01% | 4.98% | 4.39% |
Dividend Yield | 2.74% | 2.16% | 4.68% | 5.35% | 2.86% | 2.47% |
Payout Ratio | 56.40% | 41.09% | 104.10% | 38.51% | 63.08% | 30.57% |
Buyback Yield / Dilution | -3.01% | 8.24% | -14.21% | 0.18% | 4.53% | -2.16% |
Total Shareholder Return | -0.27% | 10.40% | -9.54% | 5.53% | 7.38% | 0.30% |